Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search Materials

A library of resources for the prevention,
management, and elimination of TB.

Showing 1 - 15 of 68 Results

Number of items to view
Filter Your Results
Title Year

This technical information note provides guidance to TB programme managers and quantification and procurement officers. The note includes information about the child-friendly DR-TB formulations and guidance on how to quantify and plan an order.

2023

In this webinar, Dr. Charles Peloquin presents information on the epidemiology of TB in the US. Dr. Peloquin also discusses emerging treatments for latent TB infection and for active TB disease.

Physicians Nurses
2022

This fact sheet aims to provide clinicians with general information on the presence of nitrosamine impurities found in rifampin and rifapentine and its impact on the treatment for TB.

Nurses Physicians
2022

The webinar presents information about interactions between TB medications and other drugs. This webinar is intended for physicians, nurses, and health professionals who treat and manage the care of patients with TB and LTBI.

Physicians Nurses
2021

This poster displays first-line TB treatment regimens, dosing recommendations and frequency, and adverse reactions and monitoring. The poster is 17×22 inches.

Civil Surgeons Nurses Physicians
2021

This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis...

Nurses Physicians
2020

The resource is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources.

Civil Surgeons Physicians
2020

This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information...

Persons With LTBI Physicians
2020

This handout contains information for patients that are prescribed the 4-month daily regimen of rifampin (4R) for the treatment of latent TB infection. The handout includes space to record the patient's doctor/clinic contact information. 

Persons With LTBI Physicians
2019

This handout contains information for patients that are prescribed the 3HP regimen for the treatment of latent TB infection. The 3HP regimen is a 3-month once weekly regimen of isoniazid and rifapentine. The handout includes space to record the patient's doctor/clinic contact information. 

Persons With LTBI Physicians
2019

The guide includes recommendations from the American Academy of Pediatrics on screening, diagnosis, and treatment of LTBI in children and adolescents. Topics covered include targeted testing, risk assessment, diagnostic tests, LTBI treatment regimens, and more. The guide is intended for pediatric primary care providers...

2019

This is a flipbook from the Multnomah County Health Department for patients with tuberculosis (TB) disease. The flipbook has information on TB disease, testing, case management, treatment, and more. The material is also available in Russian, Chinese, Somali, Vietnamese, and Spanish.

Health Educators/Communicators Infection Control and Occupational Health Workers Managers and Supervisors Outreach Workers
2018

The resource was designed to help healthcare providers: 1. Quickly identify and answer key questions when considering whether to start a patient on the isoniazid-rifapentine (3HP) regimen 2. Assess the appropriateness of self-administered therapy of 3HP for each individual patient 3...

Physicians
2018

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events...

Persons With LTBI Physicians
2018

This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.

2017